Review
doi: 10.1146/annurev.med.58.061705.145053.
A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis
Affiliations
- PMID: 16886905
- DOI: 10.1146/annurev.med.58.061705.145053
Item in Clipboard
Review
A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis
Annu Rev Med.
2007.
Abstract
The currently recommended treatment for individuals exposed to rabies virus is the combined administration of rabies vaccine and rabies immune globulin (RIG). This review sets out the criteria used to guide development of a cocktail of human monoclonal antibodies as a replacement for RIG. Using this process as a model, the general requirements for development of safe and efficacious monoclonal antibody alternatives to currently used polyclonal serum products are discussed.
Similar articles
-
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.J Infect Dis. 2006 Mar 15;193(6):796-801. doi: 10.1086/500470. Epub 2006 Feb 6. J Infect Dis. 2006. PMID: 16479514
-
Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.Appl Microbiol Biotechnol. 2012 Oct;96(2):357-66. doi: 10.1007/s00253-012-4171-4. Epub 2012 Jun 9. Appl Microbiol Biotechnol. 2012. PMID: 22678022
-
Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.J Infect Dis. 2003 Jul 1;188(1):53-6. doi: 10.1086/375247. Epub 2003 Jun 23. J Infect Dis. 2003. PMID: 12825170
-
Passive immunity in the prevention of rabies.Lancet Infect Dis. 2012 May;12(5):397-407. doi: 10.1016/S1473-3099(11)70340-1. Lancet Infect Dis. 2012. PMID: 22541629 Review.
-
Recombinant Monoclonal Antibodies for Rabies Post-exposure Prophylaxis.Biochemistry (Mosc). 2018 Jan;83(1):1-12. doi: 10.1134/S0006297918010017. Biochemistry (Mosc). 2018. PMID: 29534663 Review.
Cited by
-
Exploring the native human antibody repertoire to create antiviral therapeutics.Curr Top Microbiol Immunol. 2008;317:155-83. doi: 10.1007/978-3-540-72146-8_6. Curr Top Microbiol Immunol. 2008. PMID: 17990793 Free PMC article. Review.
-
The Generation of the Human mAb RabD4 Specific to the Rabies Virus Glycoprotein and Characterization Thereof.Dokl Biochem Biophys. 2019 Mar;485(1):126-128. doi: 10.1134/S1607672919020133. Epub 2019 Jun 14. Dokl Biochem Biophys. 2019. PMID: 31201631
-
Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody.J Infect Dis. 2014 Jul 15;210(2):200-8. doi: 10.1093/infdis/jiu085. Epub 2014 Feb 7. J Infect Dis. 2014. PMID: 24511101 Free PMC article.
-
Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis.EMBO Mol Med. 2016 Apr 1;8(4):407-21. doi: 10.15252/emmm.201505986. EMBO Mol Med. 2016. PMID: 26992832 Free PMC article.
-
Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.PLoS Negl Trop Dis. 2009 Nov 3;3(11):e542. doi: 10.1371/journal.pntd.0000542. PLoS Negl Trop Dis. 2009. PMID: 19888334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
